Details of the Drug
General Information of Drug (ID: DM8OMI6)
Drug Name |
Lobucavir
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
LOBUCAVIR; 127759-89-1; Cyclobut-G; C-Oxetanocin-G; C-Oxt-G; BMS-180194; Cygalovir; (+)-Cyclobut G; 2-Amino-9-((1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl)-1H-purin-6(9H)-one; Lobucavir [USAN:INN]; SQ 33054; UNII-8U5PYQ1R2E; SQ 34,514; DRG-0235; 126062-18-8; 8U5PYQ1R2E; SQ-34514; Bms 180194; 9-((1R,2R,3S)-2,3-Bis(hydroxymethyl)cyclobutyl)guanine; C11H15N5O3; Carbocyclic oxetanocin G; A-69992; 2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-3H-purin-6-one
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 265.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References